Cargando…

Current Status of COVID-19 Therapies and Drug Repositioning Applications

The rapid and global spread of a new human coronavirus (SARS-CoV-2) has produced an immediate urgency to discover promising targets for the treatment of COVID-19. Drug repositioning is an attractive approach that can facilitate the drug discovery process by repurposing existing pharmaceuticals to tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altay, Ozlem, Mohammadi, Elyas, Lam, Simon, Turkez, Hasan, Boren, Jan, Nielsen, Jens, Uhlen, Mathias, Mardinoglu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305759/ https://www.ncbi.nlm.nih.gov/pubmed/32622261 http://dx.doi.org/10.1016/j.isci.2020.101303

Ejemplares similares

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Addressing the heterogeneity in liver diseases using biological networks
por: Lam, Simon, et al.
Publicado: (2020)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
por: Li, Xiangyu, et al.
Publicado: (2021)

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
por: Altay, Ozlem, et al.
Publicado: (2019)

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
por: Li, Xiangyu, et al.
Publicado: (2022)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
por: Yuan, Meng, et al.
Publicado: (2022)

Multi-omics approaches for revealing the complexity of cardiovascular disease
por: Doran, Stephen, et al.
Publicado: (2021)

Informing Pharmacokinetic Models With Physiological Data: Oral Population Modeling of L-Serine in Humans
por: Bosley, J. R., et al.
Publicado: (2021)

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
por: Kaynar, Ali, et al.
Publicado: (2021)

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
por: Bayraktar, Abdulahad, et al.
Publicado: (2021)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
por: Bayraktar, Abdulahad, et al.
Publicado: (2023)

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
por: Yang, Hong, et al.
Publicado: (2021)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
por: Altay, Ozlem, et al.
Publicado: (2021)

Classification of clear cell renal cell carcinoma based on PKM alternative splicing
por: Li, Xiangyu, et al.
Publicado: (2020)

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
por: Zeybel, Mujdat, et al.
Publicado: (2022)

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases
por: Lam, Simon, et al.
Publicado: (2021)

New Challenges to Study Heterogeneity in Cancer Redox Metabolism
por: Benfeitas, Rui, et al.
Publicado: (2017)

Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling
por: Agren, Rasmus, et al.
Publicado: (2014)

Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
por: Kim, Woonghee, et al.
Publicado: (2023)

The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells
por: ÇADIRCI, Kenan, et al.
Publicado: (2020)

Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction
por: Arif, Muhammad, et al.
Publicado: (2021)

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
por: Zhong, Wen, et al.
Publicado: (2021)

Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet
por: Yang, Hong, et al.
Publicado: (2021)

Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
por: Yulug, Burak, et al.
Publicado: (2023)

The Potential Use of Metabolic Cofactors in Treatment of NAFLD
por: Mardinoglu, Adil, et al.
Publicado: (2019)

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022)

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
por: Lam, Simon, et al.
Publicado: (2022)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Transcriptomics resources of human tissues and organs
por: Uhlén, Mathias, et al.
Publicado: (2016)

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
por: Liao, Xinmeng, et al.
Publicado: (2023)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Discovery of Functional Alternatively Spliced PKM Transcripts in Human Cancers
por: Li, Xiangyu, et al.
Publicado: (2021)

Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies
por: Tozlu, Özlem Özdemir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60oaii73p485dsd3te2h9fptme